Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Abigail M. Lee"'
Autor:
Andrew Wilson, José Cabeçadas, Andrew Owen, Abigail M. Lee, John G. Gribben, Maria Gomes da Silva, Andrew Clear, Janet Matthews, Maria Calaminici, Rute Alvarez, Rita Coutinho
Publikováno v:
Clinical Cancer Research. 19:6686-6695
Purpose: The opportunity to improve therapeutic choices on the basis of molecular features of the tumor cells is on the horizon in diffuse large B-cell lymphoma (DLBCL). Agents such as bortezomib exhibit selective activity against the poor outcome ac
Autor:
Andreas Rosenwald, Erlend B. Smeland, T. Andrew Lister, Sameena Iqbal, Vera Grossmann, John G. Gribben, Alexander Kohlmann, George E. Wright, Lisa M. Rimsza, Claude Chelala, Nikolay Popov, German Ott, Robert Kerrin Hills, Randy D. Gascoyne, Andrew Clear, King Tan, Abigail M. Lee, Hajnalka Rajnai, Olivier Elemento, Wing C. Chan, Louis M. Staudt, Shamzah Araf, Ciaran O'Riain, Jessica Okosun, Rita M. Braziel, Janet Matthews, Torsten Haferlach, Jun Wang, Jacek Marzec, Elias Campo, András Matolcsy, Jude Fitzgibbon, Silvia Montoto, Csaba Bödör
Publikováno v:
Scopus-Elsevier
Gain of function mutations in the H3K27 methyltransferase EZH2 represent a promising therapeutic target in germinal center lymphomas. In this study, we assessed the frequency and distribution of EZH2 mutations in a large cohort of patients with folli
Autor:
Sameena Iqbal, John G. Gribben, Maria Calaminici, Paul Greaves, Abigail M. Lee, Andrew Wilson, Janet Matthews, Andrew Clear, Andrew Owen
Publikováno v:
Blood. 122:2856-2863
CD4(+) T-helper cells (THs) dominate the classical Hodgkin lymphoma (CHL) microenvironment, but their role is poorly understood. Advances in flow cytometry and immunohistochemistry permit more detailed investigation of this aspect of CHL pathophysiol
Autor:
Csaba Bödör, Lenushka Maharaj, Abigail M. Lee, John G. Gribben, Simon P. Joel, Sunil Iyengar, Andrew Clear, Maria Calaminici, Sameena Iqbal, Rebecca Auer, Janet Matthews
Publikováno v:
Blood. 121:2274-2284
Phosphoinositide-3 kinase (PI3K) pathway activation contributes to mantle cell lymphoma (MCL) pathogenesis, but early-phase studies of the PI3K p110δ inhibitor GS-1101 have reported inferior responses in MCL compared with other non-Hodgkin lymphomas
Autor:
Kelly J. Morris, Alan G. Ramsay, Andrew Clear, Maria Calaminici, Finlay MacDougall, Abigail M. Lee, Gavin Kelly, T. Andrew Lister, John G. Gribben, Simon Hallam
Publikováno v:
Blood. 115:5053-5056
Follicular lymphoma has considerable clinical heterogeneity, and there is a need for easily quantifiable prognostic biomarkers. Microvessel density has been shown to be a useful prognostic factor based on numerical assessment of vessel numbers within
Autor:
Teresa Marafioti, David Y. Mason, Margaret Jones, Lisa J. Campbell, Andrew Clear, Jacqueline Cordell, Abigail M. Lee, T. Andrew Lister, Noraidah Masir, Lindsey K. Goff
Publikováno v:
British Journal of Haematology. 144:716-725
The t(14;18)(q32;q21) chromosomal translocation induces BCL2 protein overexpression in most follicular lymphomas. However the expression of BCL2 is not always homogeneous and may demonstrate a variable degree of heterogeneity. This study analysed BCL
Autor:
Abigail M. Lee, Andreas Rosenwald, Sandra J. Horning, Gilles Salles, Wolfram Klapper, Randy D. Gascoyne, Anton Hagenbeek, Birgitta Sander, Andrew Lister, Christoph Thorns, Wanling Xie, John M. M. Raemaekers, Thierry Jo Molina, Daphne de Jong, Philippe Gaulard, Edie Weller, Elias Campo, Mukesh Chhanabhai
Publikováno v:
de Jong, D, Rosenwald, A, Chhanabhai, M, Gaulard, P, Klapper, W, Lee, A, Sander, B, Thorns, C, Campo, E, Molina, T, Norton, A, Hagenbeek, A, Horning, S, Lister, A, Raemaekers, J, Gascoyne, R D, Salles, G, Weller, E & Lunenburg Lymphoma Biomarker Consortium 2007, ' Immunohistochemical prognostic markers in diffuse large B-cell lymphoma : validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium ', Journal of Clinical Oncology, vol. 25, no. 7, pp. 805-12 . https://doi.org/10.1200/JCO.2006.09.4490
Journal of clinical pathology, 62(2), 128-138. BMJ Publishing Group
Journal of Clinical Oncology, 25(7), 805-12. American Society of Clinical Oncology
Journal of Clinical Pathology : the Journal of the Association of Clinical Pathologists, 62, 128-38
Journal of Clinical Pathology : the Journal of the Association of Clinical Pathologists, 62, 2, pp. 128-38
Journal of Clinical Oncology, 25, 7, pp. 805-12
Journal of Clinical Oncology, 25, 805-12
Journal of Clinical Pathology, 62(2), 128-38. BMJ Publishing Group
Journal of clinical oncology, 25(7), 805-812. American Society of Clinical Oncology
de Jong, D, Xie, W, Rosenwald, A, Chhanabhai, M, Gaulard, P, Klapper, W, Lee, A, Sander, B, Thorns, C, Campo, E, Molina, T, Hagenbeek, A, Horning, S, Lister, A, Raemaekers, J, Salles, G, Gascoyne, R D & Weller, E 2009, ' Immunohistochemical prognostic markers in diffuse large B-cell lymphoma : validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium) ', Journal of Clinical Pathology, vol. 62, no. 2, pp. 128-38 . https://doi.org/10.1136/jcp.2008.057257
Journal of clinical pathology, 62(2), 128-138. BMJ Publishing Group
Journal of Clinical Oncology, 25(7), 805-12. American Society of Clinical Oncology
Journal of Clinical Pathology : the Journal of the Association of Clinical Pathologists, 62, 128-38
Journal of Clinical Pathology : the Journal of the Association of Clinical Pathologists, 62, 2, pp. 128-38
Journal of Clinical Oncology, 25, 7, pp. 805-12
Journal of Clinical Oncology, 25, 805-12
Journal of Clinical Pathology, 62(2), 128-38. BMJ Publishing Group
Journal of clinical oncology, 25(7), 805-812. American Society of Clinical Oncology
de Jong, D, Xie, W, Rosenwald, A, Chhanabhai, M, Gaulard, P, Klapper, W, Lee, A, Sander, B, Thorns, C, Campo, E, Molina, T, Hagenbeek, A, Horning, S, Lister, A, Raemaekers, J, Salles, G, Gascoyne, R D & Weller, E 2009, ' Immunohistochemical prognostic markers in diffuse large B-cell lymphoma : validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium) ', Journal of Clinical Pathology, vol. 62, no. 2, pp. 128-38 . https://doi.org/10.1136/jcp.2008.057257
PurposeThe results of immunohistochemical class prediction and prognostic stratification of diffuse large B-cell lymphoma (DLBCL) have been remarkably various thus far. Apart from biologic variations, this may be caused by differences in laboratory t
Autor:
Abigail M. Lee, Donna Neuberg, Emanuele Mazzola, Maria Calaminici, Andrew Clear, Rute Alvarez, Maria Gomes da Silva, Paul Greaves, Andrew Owen, Janet Matthews, Rita Coutinho, José Cabeçadas, Andrew Wilson, John G. Gribben
Gene expression studies have identified the microenvironment as a prognostic player in diffuse large B-cell lymphoma. However, there is a lack of simple immune biomarkers that can be applied in the clinical setting and could be helpful in stratifying
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08f58059c0cd46de425a6643cbda8e01
https://europepmc.org/articles/PMC4349275/
https://europepmc.org/articles/PMC4349275/
Autor:
T. Andrew Lister, Andrew Norton, Abigail M. Lee, Maria Calaminici, Finlay MacDougall, John G. Gribben, Andrew Clear, Janet Matthews, Suzanne Jordan, Lindsey K. Goff, Andrew Davies
Publikováno v:
Journal of Clinical Oncology. 24:5052-5059
Purpose To examine the immune microenvironment in diagnostic follicular lymphoma (FL) biopsies and evaluate its prognostic significance. Patients and Methods Immunohistochemistry was used to study numbers and location of cells staining positive for i
Publikováno v:
Histopathology. 45:155-161
Aims: To define the frequency and distribution of intratubular embryonal carcinoma (IEC) in an attempt to shed light on the pathogenesis of non-seminomatous germ cell tumours (NSGCTs). Intratubular germ cell neoplasia of unclassified type (IGCNU) is